Find your next paid study

University of TennesseeNCT07225725

Actual pay is set by the research site.

Observational

Vascularized Composite Bladder Allograft Transplantation: a Phase 0 (First-in-human) Study for Deceased Donor Bladder or Combined Kidney-bladder Transplantation

The goal of this clinical trial is to demonstrate the feasibility of bladder transplantation in patients with terminal bladder diseases who would benefit from …

Bladder DiseaseBladder, NeurogenicBladder Cancer+1 more

University of California, Los AngelesNCT06337942

Actual pay is set by the research site.

A First-in-human, Open-label, Dose Escalation, Phase I Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Clinical Efficacy of M3T01 Monotherapy and in Combination With Pembrolizumab and Other Systemic Therapies in Patients With Advanced Solid Tumors

Phase 1 first-in-human, open-label, dose-escalation (3 + 3), dose-expansion clinical trial to evaluate the safety, tolerability and preliminary clinical effica…

Advanced Solid Tumors

Providence Health & ServicesNCT06719362

~$150 – $4,500

Actual pay is set by the research site.

COVID-19 Vaccines Safety Tracking: Global Consortium Study

This project aims to monitor the side effects of COVID-19 vaccines worldwide actively. The primary objectives of the project include a) to estimate the prevale…

Adverse Reaction to VaccineCOVID19 Vaccine

Pay not disclosed — ask the coordinator

Masaryk UniversityNCT04834869

Phase 2

Phase II Open Label, Single-Arm Study of Cabozantinib in Combination With Pembrolizumab in the Treatment of Locally Advanced or Metastatic Adrenocortical Carcinoma

This phase II trial tests how well cabozantinib in combination with pembrolizumab works in treating patients with adrenocortical cancer that has spread to near…

Locally Advanced Adrenal Cortex CarcinomaAdrenal Cortical CarcinomaStage III Adrenal Cortex Carcinoma+2 more

Emory UniversityNCT06006013

~$75 – $2,000

Actual pay is set by the research site.

Observational

Behavioral Resources and Awareness for Veterans With Episodic Migraine: Impact on Neurological Disability and Quality of Life

The current study will evaluate effectiveness of cognitive behavioral therapy for migraine compared to migraine education (ME) to improve migraine-related qual…

MigraineMigraine HeadacheEpisodic Migraine Headache

Yale UniversityNCT07792291

Actual pay is set by the research site.

Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Carcinoma+2 more

A Phase I Trial of Re-Irradiation With Concurrent Chemotherapy in Combination With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Squamous Cell Carcinoma

The purpose of this study is to evaluate the safety, tolerability and maximum tolerated dose of tislelizumab in combination with pamiparib plus chemoradiothera…

University of ChicagoNCT05526924

~$150 – $3,000

Actual pay is set by the research site.

Non-small Cell Lung CancerAdvanced Pancreatic AdenocarcinomaUnresectable Pancreatic Cancer+1 more

Nano-SMART: An Adaptive Phase I-II Trial of AGuIX Gadolinium-based Nanoparticles With Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Centrally Located Lung Tumors and Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma

This research study is being done to help determine the safety and efficacy of gadolinium based nanoparticle, Activation and Guidance of Irradiation X (AGuIX),…

Dana-Farber Cancer InstituteNCT04789486

~$150 – $4,500

Actual pay is set by the research site.

Observational

A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors

Up to 25% of intensive care unit (ICU) survivors experience cognitive impairment comparable in severity to mild Alzheimer's disease and related dementias after…

Critical IllnessDeliriumCognitive Impairment+5 more

University of WashingtonNCT06411561

Actual pay is set by the research site.

Advanced Malignant Solid NeoplasmMetastatic Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm+2 more

A Phase 1 Study of ZEN003694 in Combination With Binimetinib in Solid Tumors With RAS Pathway Alterations and Triple Negative Breast Cancer

This phase I trial tests the safety, side effects, and best dose of ZEN003694 in combination with binimetinib in treating patients with solid tumors that carry…

National Cancer Institute (NCI)NCT05111561

~$150 – $2,700

Actual pay is set by the research site.

Phase 3

A Global, Interventional, Open-label Trial of T-DXd-based Therapy Followed by Palbociclib, Endocrine Therapy and Dual HER2 Blockade in First-line HER2+/ HR+ Advanced or Metastatic Breast Cancer and Retreatment With T-DXd (DB-Guide)

This study will evaluate a structured sequential treatment strategy starting with T-DXd + pertuzumab upfront therapy, followed by an optimized maintenance ther…

Advanced Breast CancerMetastatic Breast CancerHER2 Positive+1 more

Daiichi SankyoNCT07683754

~$50 – $2,250

Actual pay is set by the research site.

Phase 2

Use of Gocovri to Improve Disability Due to Radiation Encephalopathy

A study to assess the effect of Gocovri (extended-release amantidine) to improve disability as assessed by the disability rating scale (DRS) and cognition as a…

EncephalopathyRadiation Effect